APA (7th ed.) Citation

Kawamura, T., Ohuchi, M., Nagasawa, T., Ohashi, H., Iwata-Yoshikawa, N., Shiwa-Sudo, N., . . . Murakami, M. (2023). 2141. Preclinical Evaluation of PA-001: A Novel, Potential Macrocyclic Peptide-Based Treatment for COVID-19 Which Binds to the S2 Subunit of SARS-CoV-2 Spike Protein. Open Forum Infectious Diseases, 10(Supplement_2), . https://doi.org/10.1093/ofid/ofad500.1764

Chicago Style (17th ed.) Citation

Kawamura, Tatsuro, et al. "2141. Preclinical Evaluation of PA-001: A Novel, Potential Macrocyclic Peptide-Based Treatment for COVID-19 Which Binds to the S2 Subunit of SARS-CoV-2 Spike Protein." Open Forum Infectious Diseases 10, no. Supplement_2 (2023). https://doi.org/10.1093/ofid/ofad500.1764.

MLA (9th ed.) Citation

Kawamura, Tatsuro, et al. "2141. Preclinical Evaluation of PA-001: A Novel, Potential Macrocyclic Peptide-Based Treatment for COVID-19 Which Binds to the S2 Subunit of SARS-CoV-2 Spike Protein." Open Forum Infectious Diseases, vol. 10, no. Supplement_2, 2023, https://doi.org/10.1093/ofid/ofad500.1764.